<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03604484</url>
  </required_header>
  <id_info>
    <org_study_id>UCLSaint Luc</org_study_id>
    <nct_id>NCT03604484</nct_id>
  </id_info>
  <brief_title>Prophylactic Tricuspid Annuloplasty During Mitral Valve Surgery</brief_title>
  <official_title>Prophylactic Tricuspid Annuloplasty During Mitral Valve Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Université Catholique de Louvain</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Université Catholique de Louvain</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Single center randomized study to test whether a prophylactic tricuspid annuloplasty at the
      time of mitral valve procedure can improve clinical and echocardiographical outcomes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The optimal management of functional tricuspid regurgitation (FTR) in the setting of mitral
      valve operations remains controversial. The current practice is both center- and
      surgeon-specific with guidelines based on non-randomized data. A prospective randomized trial
      was performed to evaluate the worth of less-than-severe FTR repair during mitral valve
      procedures.

      A single center randomized study was designed to allocate patients with less-than-severe FTR
      undergoing mitral valve surgery to be prophylactically treated + tricuspid valve annuloplasty
      (TVP- or TVP+). These patients were analysed using longitudinal cardiopulmonary exercise
      capacity, echocardiographic follow-up, and cardiac magnetic resonance (CMR). The primary
      outcome was more than mild tricuspid regurgitation (TR) recurrence with vena contracta &gt;3mm.
      Secondary outcomes were maximal oxygen uptake (VO2 max) and right ventricular (RV) dimension
      and function.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 1, 2009</start_date>
  <completion_date type="Actual">January 1, 2017</completion_date>
  <primary_completion_date type="Actual">December 31, 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of more than mild tricuspid insufficiency</measure>
    <time_frame>5 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>VO2 max</measure>
    <time_frame>1 year</time_frame>
    <description>Physical function capacity measured by VO2 max</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Right ventricular function</measure>
    <time_frame>5 year</time_frame>
    <description>Right ventricle function at the follow up</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">106</enrollment>
  <condition>Tricuspid Valve Insufficiency</condition>
  <arm_group>
    <arm_group_label>Tricuspid annuloplasty</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patient treated with tricuspid annuloplasty at the moment of the mitral valve surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Tricuspid annuloplasty</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Tricuspid annuloplasty</intervention_name>
    <description>Tricuspid annuloplasty</description>
    <arm_group_label>Tricuspid annuloplasty</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients undergoing mitral valve surgery with less than sever tricuspid insufficiency

        Exclusion Criteria:

          -  presence of pacemaker lead through the tricuspid valve

          -  acute endocarditis

          -  minimally invasive approach

          -  Functional mitral valve insufficiency
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>July 11, 2018</study_first_submitted>
  <study_first_submitted_qc>July 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 27, 2018</study_first_posted>
  <last_update_submitted>July 19, 2018</last_update_submitted>
  <last_update_submitted_qc>July 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Université Catholique de Louvain</investigator_affiliation>
    <investigator_full_name>Pettinari Matteo</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tricuspid Valve Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

